The UAE interventional
cardiology devices market is anticipated to observe an impressive growth during
the forecast period, 2023-2027. The major factors include increasing prevalence of coronary artery diseases, technological advancements, and unhealthy lifestyle. Interventional cardiology deals with the use of
catheters to treat patients suffering from heart related diseases. The
procedure uses a device such as balloon, catheter, and stent into femoral
artery or peripheral artery or vein, and then cannulating the heart. The other factor which
are bolstering the market growth are increasing
investments on healthcare sector, growing patient awareness, increase in geriatric population. Various initiatives
and awareness programs are taken by government, to raise awareness about
diseases and treatments, as well as information about the availability of more
advanced technologies and procedures at healthcare facilities.
A Rise in Unhealthy Lifestyle Habits
The increasing consumption of
processed foods, drinking alcohol, smoking and tobacco are bolstering the
growth of the market. Most of the UAE adult population is sedentary, and only
16% of young adults are physically active. This lack of physical activity can
cause obesity, hypertension, and diabetes, which lead to coronary artery
disease. A World Health Organization survey found 41 per cent of the UAE
population does not do the recommended weekly exercise. Additionally, the
increase in dietary irregularities is surging the growth of the UAE
interventional cardiology devices market. For instance, in 2017, the highest
number of deaths in the United Arab Emirates (UAE) was caused by cardiovascular
diseases at around 7.35 million deaths
Growing Prevalence of Coronary
Artery Diseases
The rise in prevalence of coronary
artery diseases is one of the major factors to drive the growth of the market. According
to the Global Health Observatory, the UAE has the second-highest cardiovascular
mortality rate. In fact, according to a new study commissioned by Cleveland
Clinic Abu Dhabi, an integral part of Mubadala Health, 55 percent of UAE
residents have been directly affected by heart disease. Therefore, the high
mortality rate and huge patient population in the UAE is anticipated to propel
the interventional cardiology devices market in the coming years.
Technological Advancements
Rapid advancements in
research and development (R&D) activities are propelling the growth of the
market as novel drugs and new products are developed for the treatment of heart
related diseases. The development of innovative bioabsorbable and drug-eluting
stents, pacemakers and drug-coated mesh tubes is also another growth-inducing
factor. For instance, in 2022, Swiss pharma company Acino launched first UAE
produced anti-cholesterol drug. Furthermore, the frequent technological
advancement for minimal invasive surgeries is driving the market growth as they
are less painful, minimize scar risk, and patients recover faster.
Download Free Sample Report
Market
Segmentation
The UAE interventional
cardiology devices market is segmented into
product, end user,
and company. Based on product,
the market is divided into
angioplasty balloons, angioplasty stents, structural heart devices, catheters,
plaque modification devices, hemodynamic flow alteration devices, and other. Based
on end user, the market is divided into hospitals
& clinics, ambulatory surgical centers, and others. In terms of region, the market is segmented
into Abu Dhabi, Dubai, Sharjah, and Rest of UAE.
Market
Players
Riomed Medical Supplies LLC, B Braun
Medical Gulf FZ-LLC, GE Healthcare UAE, Omron Healthcare UAE, Masimo
Corporation UAE, Philips Healthcare UAE, and Nihon Kohden Middle East FZE are some of the leading companies
operating in the market.
Attribute
|
Details
|
Base Year
|
2021
|
Historic Data
|
2017 –
2020
|
Estimated Year
|
2022
|
Forecast Period
|
2023
– 2027
|
Quantitative Units
|
Revenue in USD Million, Volume Units and CAGR for 2017-2021
and 2022-2027
|
Report coverage
|
Revenue forecast, Volume forecast company share, competitive
landscape, growth factors, and trends
|
Segments covered
|
·
Product
·
End User
·
Company
|
Regional scope
|
Abu Dhabi; Dubai; Sharjah;
and Rest of UAE
|
Key companies profiled
|
Riomed Medical Supplies LLC, B Braun Medical Gulf FZ-LLC, GE
Healthcare UAE, Omron Healthcare UAE, Masimo Corporation UAE, Philips
Healthcare UAE, and Nihon Kohden Middle East FZE
|
Customization scope
|
10% free report customization with purchase. Addition or alteration
to country, regional & segment scope.
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, UAE interventional
cardiology devices market has been segmented into following categories, in addition
to the industry trends which have also been detailed below:
·
UAE Interventional Cardiology Devices Market, By Product:
o
Angioplasty
Balloons
o
Angioplasty
Stents
o
Structural
Heart Devices
o
Catheters
o
Plaque
Modification Devices
o
Hemodynamic
Flow Alteration Devices
o
Other
·
UAE Interventional
Cardiology Devices Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
·
UAE Interventional
Cardiology Devices Market, By Region:
o
Abu
Dhabi
o
Dubai
o
Sharjah
o
Rest
of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major
companies present in Interventional Cardiology Devices market
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of additional market players (up to
five).
Interventional
Cardiology Devices Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]